4-HPR 65646-68-6 D08JAC Fenretinide Fenretinide (Ewing's sarcoma), Cancer Research UK Fenretinide (ILE formulation), Children's Hospital LA Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx Fenretinide (intravenous, cancer), SciTech Development Fenretinide (iv), Children's Hospital LA Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products Fenretinide (oral, AMD), Sytera Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (soft gel capsule, AMD), Sirion Fenretinide (topical, actinic keratosis and cancer), SciTech Development LXS/4-HPR N-(4-hydroxyphenyl)retinamide RT-101 ST-602 SYT-101 CAS 65646-68-6

Purity 97%+In StockPharmaceutical Standards
CAS No.65646-68-6
Molecular FormulaC26H39NO2
Molecular Weight397.59 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

4-HPR 65646-68-6 D08JAC Fenretinide Fenretinide (Ewing's sarcoma), Cancer Research UK Fenretinide (ILE formulation), Children's Hospital LA Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx Fenretinide (intravenous, cancer), SciTech Development Fenretinide (iv), Children's Hospital LA Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products Fenretinide (oral, AMD), Sytera Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (soft gel capsule, AMD), Sirion Fenretinide (topical, actinic keratosis and cancer), SciTech Development LXS/4-HPR N-(4-hydroxyphenyl)retinamide RT-101 ST-602 SYT-101 CAS 65646-68-6 chemical structure

Description

4-HPR 65646-68-6 D08JAC Fenretinide Fenretinide (Ewing's sarcoma), Cancer Research UK Fenretinide (ILE formulation), Children's Hospital LA Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx Fenretinide (intravenous, cancer), SciTech Development Fenretinide (iv), Children's Hospital LA Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products Fenretinide (oral, AMD), Sytera Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (soft gel capsule, AMD), Sirion Fenretinide (topical, actinic keratosis and cancer), SciTech Development LXS/4-HPR N-(4-hydroxyphenyl)retinamide RT-101 ST-602 SYT-101 (CAS 65646-68-6) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C26H39NO2. Molecular weight: 397.59 g/mol. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.

Physical & Chemical Properties

Molecular FormulaC26H39NO2
Molecular Weight397.59 g/mol
AppearancePale yellow to yellow crystalline powder
Purity97%+
StorageStore at 2-8°C, protect from light
Solubility (reference)Soluble in chloroform, dichloromethane, ethyl acetate, DMSO
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)8.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1975
Nitrogen Atoms1

Recommended Standards

Why CATO?